Home / Pharma News

Pharma News

Actavis sells interest in China

US generic drugmaker Actavis has sold its interest in its Chinese subsidiary based in Foshan, Guangdong, to Zhejiang Chiral Medicine Chemicals. Actavis, the second biggest generic drugmaker by market capitalization, intends to continue further commercial operations in China in collaboration with its preferred business partners.

Aurobindo to acquire seven generics businesses from Actavis

US generics maker Actavis and Indian generics maker Aurobindo Pharma (Aurobindo) announced on 17 January 2014 the signing of an offer for Aurobindo to acquire generics commercial operations in seven markets in Western Europe from Actavis.

Pfizer’s generics business up for grabs

In 2013, Pfizer, the world’s largest drugmaker, split its business into two brand-name drug units and a generics business. Now it seems the generics unit, or its ‘established products’ unit, is being circled for a potential takeover bid.

Pricing dispute causing drug shortages in Pakistan

Pharmaceutical manufacturers in Pakistan are warning the Pakistan Government that shortages in life-saving drugs are a result of the ongoing dispute over drug prices.

Ireland’s IPHA hits back at high drug prices claim

The Irish Pharmaceutical Healthcare Association (IPHA) has hit back at statements from the European Commission’s (EC’s) troika that drug prices in the country are unjustifiably high.

Health Canada approves generic oxycodone despite fears of abuse

Canada’s drug regulator Health Canada has approved a generic non-crush resistant form of oxycodone, despite the fact that US officials have been urging their Canadian counterpart to ban such formulation of the powerful painkiller.

Ireland high drug prices cannot be justified

The European Commission’s troika mission to Ireland has told Government TDs (Members of Parliament) that the cost of pharmaceutical drugs in the country cannot be justified. Drug prices in the country have been found to be at least three times more expensive than in the UK.

EMA launches public catalogue of drug shortages

The European Medicines Agency (EMA) announced on 4 November 2013 the launch of its public catalogue on supply shortages of drugs.

FDA announces two actions to combat drug shortages

The US Food and Drug Administration (FDA) announced on 31 October 2013 that it is taking two important actions to further enhance the agency’s ongoing efforts to prevent and resolve drug shortages.

Australia should not copy New Zealand’s drug pricing system

Australia should resist ongoing pressure to adopt a New Zealand-style model of medicines funding, according to Medicines Australia, a group that represents originator manufacturers.

Generics News Research General

more

Biosimilars News Research General

more